Novartis H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 East Hanover, NJ HQ🌐 novartis.com
Does Novartis sponsor H-1B visas and green cards?
Yes. Novartis has filed 2,009 H-1B LCAs and 325 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025–2026 Novartis filed 383 H-1B LCAs at a median base salary of $121,514, in line with the national H-1B median of $121,966 for the same period, and 77 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 144 | $115k |
| FY2025 | 239 | $125k |
| FY2024 | 230 | $118k |
| FY2023 | 244 | $109k |
| FY2022 | 178 | $111k |
| FY2021 | 230 | $115k |
| FY2020 | 217 | $91k |
| FY2019 | 175 | $92k |
| FY2018 | 177 | $109k |
| FY2017 | 175 | $112k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 32 | $156k |
| FY2025 | 45 | $158k |
| FY2024 | 25 | $148k |
| FY2023 | 22 | $138k |
| FY2022 | 28 | $115k |
| FY2021 | 30 | $127k |
| FY2020 | 35 | $120k |
| FY2019 | 33 | $128k |
| FY2018 | 42 | $115k |
| FY2017 | 33 | $110k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Pay against the local market
Novartis’s 10 most-filed occupations and metros. Its median base salary is 92% of the local BLS median for the same work.
| Occupation | Metro | Filings | Novartis pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Biological Scientists, All Other | Boston, MA | 114 | $92,940 | $103,120 | 90% |
| Biochemists and Biophysicists | Boston, MA | 32 | $100,722 | $127,510 | 79% |
| Medical Scientists | Boston, MA | 29 | $98,296 | $129,230 | 76% |
| Biological Scientists, All Other | San Francisco, CA | 27 | $95,127 | $125,174 | 76% |
| Biological Scientists, All Other | San Diego, CA | 22 | $81,734 | $96,933 | 84% |
| Medical Scientists | San Francisco, CA | 21 | $95,882 | $130,253 | 74% |
| Biochemists and Biophysicists | San Diego, CA | 17 | $104,734 | $109,634 | 96% |
| Chemists | Boston, MA | 15 | $89,086 | $130,830 | 68% |
| Industrial Production Managers | New York, NY | 13 | $102,861 | $135,015 | 76% |
| Software Developers | Dallas, TX | 12 | $128,250 | $110,224 | 116% |
About Novartis
Novartis is a pharma & biotech company based in Basel, Switzerland. It was founded in 1996 and has about 119,418 employees worldwide. It is listed on NYSE as NVS.
- Name (DOL filings)
- Novartis
- Listed
- NYSE: NVS
- Incorporated in
- V8
- Headquarters
- Lichtstrasse 35, Basel, V8, Ch 4056
- Industry
- Pharma & biotech
- Founded
- 1996
- H-1B filings
- 2,009
- Net income FY2025
- $14.0B +17% from $11.9B
- R&D FY2025
- $11.2B
H-1B sponsors similar to Novartis
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| CVS Health | 7,977 | 2,420 | $140k | 608 | 58% |
| Elevance Health | 6,421 | 897 | $139k | 36 | 73% |
| Optum | 5,588 | 1,038 | $126k | 120 | 69% |
| Novartis | 2,009 | 383 | $122k | 183 | 59% |
| Gilead | 1,934 | 442 | $142k | 186 | 62% |
| Genentech | 1,679 | 333 | $142k | 103 | 56% |
| Eli Lilly | 1,620 | 848 | $136k | 353 | 73% |
